“We are a small company with a big portfolio” After Martine and Jean-Paul Clozel created Actelion with two other founders and grew Actelion into Europe’s…
Herbert Reutimann, the CEO of Unitectra, the joint technology transfer organization of the Universities of Basel, Bern and Zurich, talks about the ways in which…
Giacomo di Nepi has a successful history: A high level executive in big corporations, he transitioned towards biotech, currently as CEO of Polyphor, which, in…
The competition for financing is intense. How and which projects do you choose to back? Julian Bertschinger: At Johnson & Johnson we collaborate with and…
In 2016, Roivant Sciences established their global headquarters in Basel. Roivant founder and CEO Vivek Ramaswamy talked to us about his fast growing company, his priorities…
The physician and pharmacologist Nicole Onetto is a member of the Board of Directors at the Basilea Pharmaceutica AG. In the Interview that was featured…
The physician and pharmacologist Nicole Onetto is a member of the Board of Directors at the Basilea Pharmaceutica AG. In the Interview that was featured…
The serial entrepreneur Neil Goldsmith is drawn to new ventures. Annett Altvater from BaselArea.swiss talked to him about how to detect startup-suitable talent and his…
Xconomy National — Arch Venture Partners co-founder and managing director Bob Nelsen is widely regarded as one of the most astute and successful life science investors and…